Skip to main content
TipRanks
Go Ultimate75% OFF

Aequus Pharmaceuticals (AQS) Financial Statements

14 Followers

Aequus Pharmaceuticals Financial Overview

Aequus Pharmaceuticals's market cap is currently C$663.17K. The company's EPS TTM is C$-0.01; its P/E ratio is 3.13; Aequus Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 25Mar 24Mar 23Dec 21Mar 21
Income Statement
Total RevenueC$ 584.24KC$ 254.90KC$ 1.38MC$ 2.71MC$ 2.59M
Gross ProfitC$ 199.97KC$ 143.66KC$ 1.15MC$ 2.69MC$ 2.59M
Operating IncomeC$ -2.13MC$ -2.82MC$ -2.50MC$ -1.35MC$ -521.57K
EBITDAC$ -1.79MC$ -2.68MC$ -2.87MC$ -1.23MC$ -314.80K
Net IncomeC$ -2.18MC$ -2.96MC$ -3.21MC$ -1.81MC$ -1.05M
Balance Sheet
Cash & Short-Term InvestmentsC$ 50.24KC$ 170.20KC$ 294.67KC$ 2.39MC$ 1.72M
Total AssetsC$ 800.28KC$ 1.09MC$ 1.69MC$ 4.35MC$ 3.13M
Total DebtC$ 6.61MC$ 5.06MC$ 782.92KC$ 2.18MC$ 2.32M
Net DebtC$ 6.56MC$ 4.89MC$ 533.10KC$ -211.31KC$ 604.74K
Total LiabilitiesC$ 7.26MC$ 5.38MC$ 3.07MC$ 2.56MC$ 2.56M
Stockholders' EquityC$ -6.45MC$ -4.29MC$ -1.38MC$ 1.79MC$ 573.95K
Cash Flow
Free Cash FlowC$ -1.66MC$ -2.29MC$ -1.95MC$ -1.18MC$ -817.23K
Operating Cash FlowC$ -1.66MC$ -2.29MC$ -1.95MC$ -1.17MC$ -804.91K
Investing Cash FlowC$ 44.85KC$ 0.00C$ 0.00C$ -507.96KC$ -12.32K
Financing Cash FlowC$ 1.49MC$ 2.21MC$ -189.19KC$ 2.40MC$ 2.05M

Currency in CAD

Aequus Pharmaceuticals Earnings and Revenue History

-8M-4M04M-1500 %-1000 %-500 %0 %EarningsProfit Margin20172018201920202021202220232024RevenueEarningsProfit Margin

Aequus Pharmaceuticals Liabilities to Assets

03M6M9M0 %400 %800 %1200 %LiabilitiesLiabilities to Assets20172018201920202021202220232024AssetsLiabilitiesLiabilities to Assets

Aequus Pharmaceuticals Cash Flow

-6M-4M-2M02M4M6M20172018201920202021202220232024OperatingInvestingFinancing

Aequus Pharmaceuticals Forecast EPS vs Actual EPS

000000Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25EPS EstimateBeatMiss